Geron Announces Publication of Studies Showing Oligodendrocyte Progenitors Derived From Human Embryonic Stem Cells Induce Functional Recovery After Spinal Cord Injury > Morton Cure Paralysis Fund

Research Links

Our staff has deemed the following public research links as significant and/or new findings by the global research community in the search for a cure for paralysis. You can search the database by category, keyword, name, and/or date. Keep abreast of cure research breakthroughs by signing up for our monthly research newsletter.

Please note that the research posted here is not affiliated with the MCPF unless that is specifically stated.

Geron Announces Publication of Studies Showing Oligodendrocyte Progenitors Derived From Human Embryonic Stem Cells Induce Functional Recovery After Spinal Cord Injury

Menlo Park, CA -- May 11, 2005 --

Geron Corporation (Nasdaq:GERN) announced today the publication of studies showing that oligodendrocyte progenitors, differentiated from human embryonic stem cells (hESCs), produce functional improvements in rats with spinal cord injuries. These studies provide proof of concept for the therapeutic potential of differentiated hESCs in the treatment of neurological disorders such as spinal cord injury.

In the May 11 issue of the Journal of Neuroscience, Dr. Hans Keirstead and his colleagues from the Reeve Irvine Research Center at the University of California, Irvine published studies demonstrating that hESC-derived oligodendroglial progenitor cells (OPCs) could be delivered to the injured spinal cord in rats and resulted in functional improvement in locomotion as well as histological evidence of spinal cord repair.

http://www.hypeandhope.com/wt/page/index/it_1115828571

posted @ Wednesday, May 11, 2005 12:00 AM by host